A Study of Impact of CD4 and BMI on Effectiveness of DOTS in HIV-TB Cases Registered in Hamidia Hospital Bhopal
Keywords:
DOTS, HIV-TB co-infection, CD4, BMIAbstract
Background: TB is the leading cause of morbidity and mortality among people living with HIV. The treatment for TB is same for HIV infected as for non-HIV infected TB patients. The same criteria determine the treatment category for TB patients irrespective of the HIV Status.
Objectives: The objectives were to study outcome of DOTS in HIV-TB cases; to study the comparison of outcome of DOTS in HIV-TB and TB cases; and to study effects of different factors on outcome of DOTS in HIV-TB and TB cases.
Material and method: Hospital based cross-sectional study was carried out in ART and DOTS center. 98 cases of HIV-TB co-infection and 150 cases of only TB infection were interviewed and BMI and CD4 of all cases of both the group were collected. All cases were observed to see the outcome and factors affecting outcome were studied separately.
Result: cure rate in HIV-TB cases was 12.2% and in TB was 40%. Treatment completion rate was 51% in HIV-TB and 19.3% in TB cases. The study found that BMI was affecting outcome in both group while CD4 count affecting outcome in HIV-TB cases.
Conclusion: The study indicated that cure rate improved as BMI and CD4 count increased.
References
WHO (2010) Global TB control 2010- http://www. int/tb/publications/global-report2010/en/index.html.
Aarol L, Saadoun D, Calatronl, Launay O, Memain N, et al, TB in HIV infected patients:a comprehensive review. Clinical Microbiology and Infection, Official publication of ESCMID, May 2004; 10(5):388–398.
WHO media centre, Tuberculosis Fact sheet (reviewed 2017), Available at http://www.who.int/mediacentre/ factsheets/fs104/en/
Bucher HCGriffith LEGuyatt GH et al. Isoniazid prophylaxis therapy for tuberculosis in HIV infected adults: a systematic review and meta-analysis of randomized trials. AIDS.1999; Mar 11;13(4):501-7
Selwyn PAHartel D Lewis VA et al. A prospective study of the risk of Tuberculosis among intravenous drug users with human immunodeficiency virus infection.N Engl J Med. 1989 Mar 2;320(9):545-50.
Girardi Eraviglione MC Antonucci Godfrey-Faussett Pippolito et al. Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS. 2000;14 (suppl 3) S47- S56
World Health Organization. WHO Report 2011: Global Tuberculosis Control. 2011
HIV associated TB facts 2013 available at http://www. who.int/tb/challenges/hiv/tbhiv_factsheet_2013_web.pdf
UNAIDS (2010) chapter2:epdemic update. UNAIDS report on the global AIDS epidemic 2010.Available at http:// www.unaids.org/documents/201011123_Globalreport_Chap2_em.pdf
New WHO guidelines: TB prevention for people with HIV. Available at http://www.who.int/mediacentre/news/ re-leases/2010/wad_20101201/en/
George W. Comstock , 5 Reviews and Commentary, Frost revisited: the modern epidemiology of Tuberculosis the Third Wade Hampton Frost lecture1 - American Journal Of Epidemiology, (formerly American Journal of Hygiene) 1975; 101.
R. Zachariah Opens, F.M.L. Salaniponi et al.Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Transactions of the Royal Society of Tropical Medicine and Hygiene 2002; 96(3):291-294
Heidi van Rooyen, Ruanne V. Barnabas et al. High HIV testing uptake and linkage to care in a novel program of home_based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa.J Acquir Immune Defic Syndr. 2013 Sep 1; 64(1): e1–e8.
Michael Carter , TB Treatment, ART during Tuberculosis therapy reduces mortality risk for people with HIV ,NAM(AIDSMAP), (para 11)
Odone Anna et al. The Impact of Antiretroviral Therapy on Mortality in HIV Positive People during Tuberculosis Treatment: A Systematic Review and Meta-Analysis. PLoS One. 2014 Nov 12;9(11):e112017
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
